Dog Myasthenia Gravis: Treatment and Welfare Management

Myasthenia gravis is a neuromuscular disease causing progressive muscle weakness in dogs, with megaesophagus and aspiration pneumonia as the most life-threatening welfare complications.

Key Facts

Myasthenia gravis (MG) is caused by autoantibodies destroying acetylcholine receptors at the neuromuscular junction, impairing nerve-to-muscle signalling
Acquired MG is the most common form in dogs; a congenital form also exists, affecting certain breeds including Jack Russell Terriers
Golden Retrievers, German Shepherds, Labrador Retrievers and Akitas are among the most commonly affected breeds
The hallmark clinical sign is exercise-induced weakness that worsens with activity and improves with rest
Megaesophagus — loss of oesophageal motility causing food and liquid to pool — affects approximately 90% of dogs with MG
Aspiration pneumonia secondary to megaesophagus is the leading cause of death in MG dogs
Pyridostigmine bromide (an acetylcholinesterase inhibitor) is the primary treatment, improving neuromuscular transmission
Spontaneous remission occurs in approximately 50% of acquired MG cases, typically within 6-18 months of diagnosis

Welfare Considerations

Myasthenia gravis creates a complex and distressing welfare situation. Dogs experience progressive weakness that limits their ability to perform basic behaviours — exercise, play and even posture maintenance become exhausting or impossible. The psychological impact of being unable to do previously normal activities is difficult to assess but likely significant. Megaesophagus creates a constant choking and regurgitation risk: affected dogs must be fed in an elevated position (Bailey chair) for 10-20 minutes after every meal, a lifelong management requirement that is stressful for both dog and owner. Aspiration pneumonia causes acute respiratory distress and is painful, often requiring hospitalisation. Treatment with pyridostigmine can cause gastrointestinal cramping and hypersalivation. The uncertainty of whether spontaneous remission will occur means owners and vets must balance intensive management against quality of life over an unpredictable timeframe. Dogs in remission can return to full normal function.

What You Can Do

If your dog shows exercise-induced weakness or regurgitation, consult a veterinarian promptly — MG is diagnosable with the acetylcholine receptor antibody test
Learn Bailey chair feeding technique if your dog has megaesophagus — proper positioning reduces aspiration risk dramatically
Follow your vet's pyridostigmine dosing schedule precisely — underdosing causes weakness, overdosing causes choking crises
Monitor for signs of aspiration pneumonia: coughing after eating, fever, rapid breathing or laboured breathing
Join the Canine Myasthenia Gravis owner community — shared experience with Bailey chairs and medication management is invaluable
Work with a veterinary neurologist for complex cases — MG management benefits from specialist expertise
Maintain hope: spontaneous remission in 50% of cases means many MG dogs eventually return to normal life